TGFB1 and cancer: Tumor with HPD show reduced immunogenicity, increased immunosuppressive cells, mutations in cancer suppressor genes, and activation of ERK/MAPK, PI3K/AKT, TGF-β, and Insulin-like growth factor 1 (IGF-1) pathways, when compared to tumor without prior HPD [244].